Detalhe da pesquisa
1.
Efficacy of FOLFIRI plus cetuximab vs FOLFIRI plus bevacizumab in 1st-line treatment of older patients with RAS wild-type metastatic colorectal cancer: an analysis of the randomised trial FIRE-3.
Br J Cancer
; 127(5): 836-843, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35637412
2.
Value of infliximab (Remicade®) in patients with low-risk myelodysplastic syndrome: final results of a randomized phase II trial (EORTC trial 06023) of the EORTC Leukemia Group.
Haematologica
; 97(4): 529-33, 2012 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-22102701
3.
First-line fluoropyrimidine plus bevacizumab followed by irinotecan-escalation versus initial fluoropyrimidine, irinotecan and bevacizumab in patients with metastatic colorectal cancer - Final survival and per-protocol analysis of the randomised XELAVIRI trial (AIO KRK 0110).
Eur J Cancer
; 173: 194-203, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35940054
4.
Response and Disease Dynamics in Untreated Metastatic Colorectal Cancer With Bevacizumab-Based Sequential vs. Combination Chemotherapy-Analysis of the Phase 3 XELAVIRI Trial.
Front Oncol
; 12: 751453, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35251955
5.
A randomized, phase III trial of capecitabine plus bevacizumab (Cape-Bev) versus capecitabine plus irinotecan plus bevacizumab (CAPIRI-Bev) in first-line treatment of metastatic colorectal cancer: the AIO KRK 0110 trial/ML22011 trial.
BMC Cancer
; 11: 367, 2011 Aug 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-21861888
6.
The CysLT1 ligand leukotriene D4 supports alpha4beta1- and alpha5beta1-mediated adhesion and proliferation of CD34+ hematopoietic progenitor cells.
J Immunol
; 182(11): 6789-98, 2009 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19454674
7.
Signet ring cell carcinoma of the stomach is significantly associated with poor prognosis and diffuse gastric cancer (Lauren's): single-center experience of 160 cases.
Onkologie
; 34(12): 682-6, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-22156447
8.
Immunopeptidomics-Guided Warehouse Design for Peptide-Based Immunotherapy in Chronic Lymphocytic Leukemia.
Front Immunol
; 12: 705974, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34305947
9.
Gender-dependent survival benefit from first-line irinotecan in metastatic colorectal cancer. Subgroup analysis of a phase III trial (XELAVIRI-study, AIO-KRK-0110).
Eur J Cancer
; 147: 128-139, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33647548
10.
Consensus molecular subtypes in metastatic colorectal cancer treated with sequential versus combined fluoropyrimidine, bevacizumab and irinotecan (XELAVIRI trial).
Eur J Cancer
; 157: 71-80, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34507244
11.
Impact of age on efficacy and early mortality of initial sequential treatment versus upfront combination chemotherapy in patients with metastatic colorectal cancer: a subgroup analysis of a phase III trial (AIO KRK0110, XELAVIRI study).
Eur J Cancer
; 137: 81-92, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32750502
12.
Sequential Versus Combination Therapy of Metastatic Colorectal Cancer Using Fluoropyrimidines, Irinotecan, and Bevacizumab: A Randomized, Controlled Study-XELAVIRI (AIO KRK0110).
J Clin Oncol
; 37(1): 22-32, 2019 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30388045
13.
Eltrombopag for advanced myelodysplastic syndromes or acute myeloid leukaemia and severe thrombocytopenia (ASPIRE): a randomised, placebo-controlled, phase 2 trial.
Lancet Haematol
; 5(1): e34-e43, 2018 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-29241762
14.
Cyclopentenone prostaglandins induce caspase activation and apoptosis in dendritic cells by a PPAR-gamma-independent mechanism: regulation by inflammatory and T cell-derived stimuli.
Exp Hematol
; 30(9): 1020-8, 2002 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-12225793
15.
Sequential administration of gemtuzumab ozogamicin and conventional chemotherapy as first line therapy in elderly patients with acute myeloid leukemia: a phase II study (AML-15) of the EORTC and GIMEMA leukemia groups.
Haematologica
; 89(8): 950-6, 2004 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-15339678
16.
Nonpeptide mediators in the hematopoietic microenvironment.
Ann N Y Acad Sci
; 996: 61-6, 2003 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-12799283
17.
Serum levels of CD137 ligand and CD178 are prognostic factors for progression of myelodysplastic syndrome.
Leuk Lymphoma
; 45(2): 301-8, 2004 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-15101715
18.
Sulfur-related air pollutants induce the generation of platelet-activating factor, 5-lipoxygenase- and cyclooxygenase-products in canine alveolar macrophages via activation of phospholipases A2.
Prostaglandins Other Lipid Mediat
; 71(3-4): 217-34, 2003 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-14518563
19.
Use of veno-venous bypass for resection of malignant pheochromocytoma with vena caval thrombus.
Int Urol Nephrol
; 34(2): 241-3, 2002.
Artigo
em Inglês
| MEDLINE | ID: mdl-12775104
20.
Potential role of cysteinyl leukotrienes in trafficking and survival of hematopoietic progenitor cells.
Adv Exp Med Biol
; 525: 25-8, 2003.
Artigo
em Inglês
| MEDLINE | ID: mdl-12751731